⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5580081 | 1.00 | — | — | |
| SCHEMBL7690945 | 0.73 | — | — | |
| SCHEMBL14456626 | 0.72 | — | — | |
| SCHEMBL818784 | 0.72 | — | — | |
| SCHEMBL818785 | 0.72 | — | — | |
| SCHEMBL501122 | 0.67 | — | — | |
| SCHEMBL11026359 | 0.67 | — | — | |
| SCHEMBL1331275 | 0.67 | — | — | |
| SCHEMBL5764518 | 0.67 | — | — | |
| SCHEMBL186452 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7220783-B2 | Para-terphenyl compounds | SHIONOGI & CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7101915-B1 | P-terphenyl compounds | SHIONOGI & CO., LTD. (JP) | 2006-09-05 | — | — | US | disclosed |
| US-7074836-B1 | SUPPRESSION CELL DIFFERENTIATION OF CELL INTO ANTIBODY; SUPPRESS IMMONOGLOBULINS; ANTIALLERGENS | SHIONOGI & CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| US-20040127495-A1 | Novel para-terphenyl compounds | SHIONOGI & CO., LTD. | 2004-07-01 | — | — | US | disclosed |
| EP-0933346-B1 | NOVEL p-TERPHENYL COMPOUNDS | SHIONOGI & CO (JP) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002020487-A1 | SUBSTITUTED 1-ARYL-PYRIDIN-2-(THI)ONES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-14 | — | — | WO | disclosed |
| EP-0933346-A1 | NOVEL p-TERPHENYL COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 1999-08-04 | — | — | EP | disclosed |